BUSINESS BRIEFING / PHARMACEUTICALS
- Share via
Times Wire Reports
Swiss pharmaceutical giant Roche said it had completed its $46.8-billion takeover of San Francisco biotech firm Genentech. Roche, which already held 55.7% of Genentech stock, said it acquired a further 37.5% of shares by the offer deadline Wednesday.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
